XTL Biopharmaceuticals Ltd (H2K2) — Cash Flow Quality Index
XTL Biopharmaceuticals Ltd (H2K2) has a Cash Flow Quality Index of -2.41x as of December 2021. Operating cash flow of €-1.05 Million is below net income of €435.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore H2K2 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
XTL Biopharmaceuticals Ltd Cash Flow Quality Index (2018–2021)
Historical Cash Flow Quality Index for XTL Biopharmaceuticals Ltd across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see H2K2 operating cash flow.
Annual Cash Flow Quality Index for XTL Biopharmaceuticals Ltd (2018–2021)
Year-by-year earnings quality comparison for XTL Biopharmaceuticals Ltd.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -2.41x | €-1.05 Million | €435.00K | ▼ -972.8% |
| 2018 | -0.22x | €-816.00K | €3.63 Million | — |